Pediatric patients receiving ABO-incompatible living related liver transplantation exhibit higher serum transforming growth factor-β1, interferon-γ and interleukin-2 levels

Pediatric Surgery International

Volumn 27, Issue 3, 2011, Pages 263-268

  Hussein, Mohamed Hamed ^a,b,c   Hashimoto, Takashi ^a   Abdel Hamid Daoud, Ghada ^b   Kato, Takazumi ^a   Hibi, Masahito ^a   Tomishige, Hirokazu ^a   Hara, Fujio ^a   Suzuki, Tatsuya ^c   Nakajima, Yoko ^c   Goto, Tatenobu ^c   Ito, Tetsuya ^c   Kato, Ineko ^c   Sugioka, Atsushi ^a   Togari, Hajime ^c  

^a FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b VACSERA   (Egypt)

^c NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

Author keywords

Blood group; Cytokines; Organ transplantation; Rejection

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; GAMMA GLUTAMYLTRANSFERASE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; LACTATE DEHYDROGENASE; TRANSFORMING GROWTH FACTOR BETA1;

ADOLESCENT; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; BLOOD DONOR; BLOOD GROUP ABO INCOMPATIBILITY; BLOOD GROUP ABO SYSTEM; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DONOR SELECTION; FEMALE; FOLLOW UP; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GRAFT RECIPIENT; GRAFT REJECTION; HUMAN; LACTATE DEHYDROGENASE BLOOD LEVEL; LIVER TRANSPLANTATION; LIVING DONOR; MALE; OUTPATIENT CARE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCHOOL CHILD; TH1 CELL;

ABO BLOOD-GROUP SYSTEM; ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; GRAFT SURVIVAL; HUMANS; INFANT; INTERFERON-GAMMA; INTERLEUKIN-2; LIVER FUNCTION TESTS; LIVER TRANSPLANTATION; LIVING DONORS; MALE; STATISTICS, NONPARAMETRIC; TRANSFORMING GROWTH FACTOR BETA1; YOUNG ADULT;

EID: 79954442596     PISSN: 01790358     EISSN: 14379813     Source Type: Journal    
DOI: 10.1007/s00383-010-2784-1     Document Type: Article

References (19)

1. M Spada B Gridelli M Colledan A Segalin A Lucianetti W Petz S Riva G Torre 2000 Extensive use of split liver for pediatric liver transplantation: a single-center experience Liver Transpl 6 4 415 428 10.1053/jlts.2000.7570 1:STN:280:DC%2BD3M%2FitVOjsQ%3D%3D 10.1053/jlts.2000.7570 10915162 (Pubitemid 30489113)
2. C Toso M Al-Qahtani FA Alsaif DL Bigam GA Meeberg AM James Shapiro VG Bain NM Kneteman 2007 Abo-incompatible liver transplantation for critically ill adult patients Transpl Int 20 8 675 681 10.1111/j.1432-2277.2007.00492.x 10.1111/j.1432-2277.2007.00492.x 17521384 (Pubitemid 47024915)
3. J Pratschke SG Tullius 2007 Promising recent data on abo incompatible liver transplantation: restrictions may apply Transpl Int 20 8 647 648 10.1111/j.1432-2277.2007.00515.x 10.1111/j.1432-2277.2007.00515.x 17610466 (Pubitemid 47024924)
4. H Egawa F Oike L Buhler AM Shapiro S Minamiguchi H Haga K Uryuhara T Kiuchi S Kaihara K Tanaka 2004 Impact of recipient age on outcome of abo-incompatible living-donor liver transplantation Transplantation 77 3 403 411 10.1097/01.TP.0000110295.88926.5C 10.1097/01.TP.0000110295.88926.5C 14966415 (Pubitemid 38209740)
5. K Kozaki H Egawa M Kasahara F Oike A Yoshizawa A Fukatsu K Tanaka 2005 Therapeutic strategy and the role of apheresis therapy for abo incompatible living donor liver transplantation Ther Apher Dial 9 4 285 291 10.1111/j.1744-9987.2005.00304.x 10.1111/j.1744-9987.2005.00304.x 16076368 (Pubitemid 41800795)
6. N Kawagishi I Takeda S Miyagi K Satoh Y Akamatsu S Sekiguchi K Fujimori T Sato S Satomi 2007 Management of anti-allogeneic antibody elimination by apheresis in living donor liver transplantation Ther Apher Dial 11 5 319 324 TAP506[pii].10.1111/j.1744-9987.2007.00506.x 10.1111/j.1744-9987.2007.00506.x 17845390 (Pubitemid 47383412)
7. E Mor D Skerrett C Manzarbeitia PA Sheiner ME Schwartz S Emre SN Thung CM Miller 1995 Successful use of an enhanced immunosuppressive protocol with plasmapheresis for abo-incompatible mismatched grafts in liver transplant recipients Transplantation 59 7 986 990 1:STN:280:DyaK2M3isVOquw%3D%3D 10.1097/00007890-199504150-00011 7709460
8. WA Border NA Noble 1994 Transforming growth factor beta in tissue fibrosis N Engl J Med 331 19 1286 1292 1:CAS:528:DyaK2MXitlGksrs%3D 10.1056/NEJM199411103311907 7935686 (Pubitemid 24333194)
9. R Reding J Gras DQ Truong G Wieers D Latinne 2006 The immunological monitoring of alloreactive responses in liver transplant recipients: a review Liver Transpl 12 3 373 383 10.1002/lt.20704 10.1002/lt.20704 16498661
10. T Asakura N Ohkohchi S Satomi 2000 Changes of serum cytokines associated with hepatic regeneration after living-related liver transplantation Transplant Proc 32 7 2199 2203 1:CAS:528:DC%2BD3cXovFKhs7k%3D 10.1016/S0041-1345(00)01634-1 11120132
11. F Conti J Frappier S Dharancy C Chereau D Houssin B Weill Y Calmus 2003 Interleukin-15 production during liver allograft rejection in humans Transplantation 76 1 210 216 10.1097/01.TP.0000067530.95852.67 1:CAS:528:DC%2BD3sXlsVymsLs%3D 10.1097/01.TP.0000067530.95852.67 12865812 (Pubitemid 36877139)
12. F Conti Y Calmus E Rouer P Gaulard A Louvel D Houssin ES Zafrani 1999 Increased expression of interleukin-4 during liver allograft rejection J Hepatol 30 5 935 943 1:STN:280:DyaK1M3ptF2ntw%3D%3D 10.1016/S0168-8278(99)80150-0 10365823 (Pubitemid 29248997)
13. Y Kita Y Iwaki K Noguchi BP Griffith AG Tzakis S Todo JJ Fung TE Starzl 1996 Daily serum interleukin-6 monitoring in multiple organ transplantation with or without liver allografts Transplant Proc 28 3 1229 1234 1:STN:280: DyaK283lsleqsg%3D%3D 8658638 (Pubitemid 26195180)
14. H Sankary A Chong E Frye P Scuderi P Foster L McChesney J Williams 1993 Daily determinations of serum lymphotoxin allows for accurate early diagnosis of hepatic allograft rejection Transplant Proc 25 1 Pt 2 928 930 1:STN:280:DyaK3s7ot1antw%3D%3D 8442270 (Pubitemid 23078842)
15. R Ganschow DC Broering D Nolkemper J Albani MJ Kemper X Rogiers M Burdelski 2001 Th2 cytokine profile in infants predisposes to improved graft acceptance after liver transplantation Transplantation 72 5 929 934 1:CAS:528:DC%2BD3MXns1Kjuro%3D 10.1097/00007890-200109150-00031 11571461 (Pubitemid 32879869)
16. A Minguela A Torio L Marin F Sanchez-Bueno AM Garcia-Alonso J Ontanon P Parrilla MR Alvarez-Lopez 1999 Implication of th1, th2, and th3 cytokines in liver graft acceptance Transplant Proc 31 1-2 519 520 1:STN:280: DyaK1M7ot1OrtA%3D%3D 10.1016/S0041-1345(98)02110-1 10083217 (Pubitemid 29127554)
17. CL Lin FS Wang YR Kuo YT Huang HC Huang YC Sun YH Kuo 2006 Ras modulation of superoxide activates erk-dependent fibronectin expression in diabetes-induced renal injuries Kidney Int 69 9 1593 1600 10.1038/sj.ki.5000329 1:CAS:528:DC%2BD28XjvF2ks7s%3D 10.1038/sj.ki.5000329 16572112
18. SL Friedman 1993 Seminars in medicine of the Beth Israel Hospital, Boston. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies N Engl J Med 328 25 1828 1835 1:STN:280:DyaK3s3nsFersg%3D%3D 10.1056/NEJM199306243282508 8502273 (Pubitemid 23174715)
19. H Tashiro Y Fudaba H Itoh K Mizunuma H Ohdan T Itamoto T Asahara 2003 Hepatocyte growth factor prevents chronic allograft dysfunction in liver-transplanted rats Transplantation 76 5 761 765 10.1097/01.TP.0000083040. 50727.CE 1:CAS:528:DC%2BD3sXnsVKis7o%3D 10.1097/01.TP.0000083040.50727.CE 14501849 (Pubitemid 37140215)